Johnson & Johnson
American multinational pharmaceutical and consumer goods corporation
Follow Johnson & Johnson on Notably News to receive short updates to your email — rarely!
| March 2025 | Company's market capitalization was valued at over $394 billion, with shares trading at over $165 per share. |
| February 2025 | Johnson & Johnson offered a $10 billion settlement to end over 62,000 talc-based powder related lawsuits, seeking approval from bankruptcy judge Christopher Lopez. |
| 2024 | Johnson & Johnson reported annual earnings of $14.07 billion with a total revenue of $88.82 billion for the fiscal year. |
| May 2024 | Johnson & Johnson acquired Proteologix for $850 million. |
| April 2024 | Johnson & Johnson acquired Shockwave Medical for $13.1 billion. |
| January 2024 | Johnson & Johnson acquired Ambrx Biopharma for $2 billion. |
| 2023 | Johnson & Johnson announced it would stop making talc-based powder and offered $9 billion to settle lawsuits, with the number of talc-related lawsuits exceeding 40,000. |
| 2023 | Joaquin Duato becomes chairman, the most recent leader in Johnson & Johnson's long history of leadership succession. |
| 2023 | The Institute for Clinical and Economic Review (ICER) identified Darzalex, a drug developed by Johnson & Johnson, as one of five high-expenditure drugs with significant net price increases. The drug's wholesale acquisition cost rose by approximately 7.6%, resulting in an additional $190 million in costs to U.S. payers. |
| 2023 | Substantial improvement in net income to $35,153 million, despite employee count reducing to 131,900, with revenue increasing to $85,159 million. |
| 2023 | The company split off its consumer healthcare business segment into a new publicly traded company called Kenvue, transforming its business focus to pharmaceutical and medical device technologies. |
| July 24 2023 | Johnson & Johnson launched an exchange offer to split-off Kenvue, reducing its stake to approximately 9.5%. |
| July 13 2023 | Stop TB Partnership announced licenses to produce generic versions of the tuberculosis drug bedaquiline after negotiations with Johnson & Johnson. |
| May 2023 | Kenvue went public through an IPO, with Johnson & Johnson maintaining a controlling stake of around 91 percent. |
| 2022 | Revenue declines to $79,990 million, but net income remains strong at $17,941 million, with employee count reaching 155,800. |
| December 2022 | Johnson & Johnson acquired cardiovascular medical technology company Abiomed Inc. for $16.6 billion. |
| September 2022 | A A$300 million compensation agreement was reached between Shine Lawyers and Johnson & Johnson in the Australian vaginal mesh implants case, pending Federal Court approval. |
| September 2022 | Johnson & Johnson chose Kenvue as the new name for its Consumer Health business. |
| January 2022 | Johnson & Johnson agreed to pay up to $5 billion as part of a $26 billion settlement with several pharmaceutical distributors to resolve opioid epidemic lawsuits. |
| January 2022 | Joaquin Duato became CEO of Johnson & Johnson. |
| 2021 | Johnson & Johnson subsidiary LTL Management LLC filed for Chapter 11 bankruptcy in North Carolina to manage talc-related litigation liabilities. |
| 2021 | Significant revenue increase to $93,775 million, with net income rising to $20,878 million and employee count growing to 141,700. |
| November 2021 | Johnson & Johnson began the separation of their consumer healthcare business segment. |
| 2020 | Johnson & Johnson announced discontinuation of talc-based baby powder sales in the United States and Canada. |
| 2020 | Despite the COVID-19 pandemic, Johnson & Johnson maintains stable revenue at $82,584 million and increases employee count to 134,500. |
| November 2020 | Johnson & Johnson acquired Momenta Pharmaceuticals for $6.5 billion. |
| March 10 2020 | Died from cancer at his home in Key West, Florida at the age of 89. |
| March 10 2020 | Passed away, leaving behind a legacy of innovative life-size bronze statues depicting everyday human activities. |
| 2019 | Company experiences a slight decrease in net income to $15,119 million, with employee count reducing to 132,200. |
| 2019 | Johnson & Johnson announced the release of photochromic contact lenses that adjust to sunlight and help eyes recover from bright light exposure. |
| 2019 | Received the International Sculpture Center's Lifetime Achievement Award, recognizing his significant contributions to sculpture. |
| November 2019 | The Federal Court of Australia found Johnson & Johnson negligent in the vaginal mesh implants case. |
| October 2019 | Johnson & Johnson paid $20.4 million to two Ohio counties to settle opioid-related litigation. |
| October 2019 | Johnson & Johnson reached a settlement with 41 US states and the District of Columbia in a lawsuit alleging deceptive marketing of transvaginal surgical-mesh devices, settling for approximately $117 million. |
| August 26 2019 | An Oklahoma judge ordered Johnson & Johnson to pay $572 million for its role in the opioid crisis. |
| May 2019 | The first major opioid-related trial began in Oklahoma against Johnson & Johnson. |
| March 2019 | The FDA approved esketamine for treating severe depression, marketed as Spravato by Janssen Pharmaceuticals. |
| 2018 | Johnson & Johnson became embroiled in the opioid epidemic, facing over 500 opioid-related lawsuits across the United States. |
| 2018 | Johnson & Johnson reports annual revenue of $81,581 million with 134,000 employees, maintaining a strong market position. |
| August 2018 | J&J announced removal of several chemicals from baby powder products and re-engineered them to improve consumer confidence in product safety. |
| 2017 | A California jury ordered Johnson & Johnson to pay $417 million to a woman who claimed she developed ovarian cancer after using talc-based baby powder products. |
| 2017 | Over 700 women in Australia initiated a class action lawsuit against Johnson & Johnson in the Federal Court of Australia, alleging serious complications from vaginal mesh implants. |
| 2017 | Johnson & Johnson acquired Abbott Medical Optics from Abbott Laboratories for $4.325 billion and acquired Actelion in a $30 billion deal, the largest purchase in company history. |
| September 2017 | Johnson & Johnson acquired subscription-based contact lens startup Sightbox and acquired Emerging Implant Technologies GmbH, a manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery. |
| July 2017 | Johnson & Johnson Vision Care, Inc acquired TearScience. |
| 2016 | J&J was ordered to pay $72 million in damages to the family of Jacqueline Fox, a 62-year-old woman who died of ovarian cancer in 2015, related to talc-based baby powder. |
| 2016 | California and Washington states filed a lawsuit against Johnson & Johnson, accusing the company of deception regarding vaginal mesh implants. |
| November 2015 | Biosense Webster, Inc. acquired Coherex Medical Inc., expanding treatment options for patients with atrial fibrillation. |
| 2012 | Johnson & Johnson pulled vaginal mesh implants from the US market due to significant complications and legal concerns. |
| 2012 | Alex Gorsky became chairman and CEO of Johnson & Johnson. |
|
We are only showing the most recent entries for this topic. |
|
This contents of the box above is based on material from the Wikipedia articles John Seward Johnson II & Johnson & Johnson, which are released under the Creative Commons Attribution-ShareAlike 4.0 International License.